Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REMIFENTANIL Cause Neuromuscular block prolonged? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Neuromuscular block prolonged have been filed in association with REMIFENTANIL (Remifentanil Hydrochloride). This represents 0.7% of all adverse event reports for REMIFENTANIL.

20
Reports of Neuromuscular block prolonged with REMIFENTANIL
0.7%
of all REMIFENTANIL reports
0
Deaths
7
Hospitalizations

How Dangerous Is Neuromuscular block prolonged From REMIFENTANIL?

Of the 20 reports, 7 (35.0%) required hospitalization, and 5 (25.0%) were considered life-threatening.

Is Neuromuscular block prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REMIFENTANIL. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does REMIFENTANIL Cause?

Anaphylactic shock (351) Hypotension (195) Anaphylactic reaction (178) Cardiac arrest (145) Bradycardia (132) Foetal exposure during pregnancy (132) Drug ineffective (112) Off label use (109) Anaesthetic complication neurological (96) Premature baby (91)

What Other Drugs Cause Neuromuscular block prolonged?

ROCURONIUM (122) FENTANYL (35) SUCCINYLCHOLINE (35) PROPOFOL (33) SUGAMMADEX (33) VECURONIUM (25) HYDROCORTISONE (11) SEVOFLURANE (11) DESFLURANE (10) METAMIZOLE (10)

Which REMIFENTANIL Alternatives Have Lower Neuromuscular block prolonged Risk?

REMIFENTANIL vs REMIMAZOLAM REMIFENTANIL vs REMODULIN REMIFENTANIL vs REPAGLINIDE REMIFENTANIL vs REPOTRECTINIB REMIFENTANIL vs REQUIP

Related Pages

REMIFENTANIL Full Profile All Neuromuscular block prolonged Reports All Drugs Causing Neuromuscular block prolonged REMIFENTANIL Demographics